Roughly $12 million worth of HIV-prevention drugs and contraceptives purchased by the U.S. Agency for International ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

(Reuters) -Gilead Sciences says it still plans to supply its twice-yearly injection for preventing HIV infection in ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and increase access to a medication used to prevent HIV.

A study published in Med has found that the HIV medication lamivudine significantly improved visual acuity in adults with ...